Developer docs
API playgroundTry for free, no card

Search company profiles

Frontier Space Technologies

Full company profile

uuid0009b6v

Namestring
Frontier Space Technologies
Legal namestring
Frontier Space Technologies Ltd
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Frontier Space Technologies Ltd is a UK private space-biotech company founded in 2021 as a spin-out from Cranfield University by four graduates of the BAMMsat programme. The company develops SpaceLab, a CubeSat-specification, modular, autonomous "lab-in-a-box" platform that enables pharmaceutical R&D and biomanufacturing in microgravity. SpaceLab integrates a proprietary Multi Chamber Sample Disc delivering 4x sample density in a shoebox form factor, fluorescence microscopy and spectrometry sensors, advanced environmental control, and microfluidics for in-orbit cell culture and protein crystallisation. Two generations have been validated: SpaceLab Mark 1 (1.2U demonstrator) on the EGGS-1 mission in April 2025, and SpaceLab Mk 2 on the EGGS-2 mission in January 2026, the latter carrying 42 Azenta FluidX sample tubes and achieved in a roughly four-month design-to-launch cycle.

The business operates a platform-plus-services model, earning revenue from tiered orbital research services ranging from £1,200 entry-level passive sample testing through fully customised multi-year missions with bespoke thermal, atmospheric, and fluidic controls and onboard imaging. Distribution combines direct enterprise sales into pharma and biotech, channel partnerships with multiple launch providers and spacecraft OEMs (ATMOS Space Cargo, The Exploration Company, Orbital Paradigm), and government-funded programmes including UKSA IBF and AIEP. Customers span pharmaceutical and biotechnology firms (primary), academic and government research institutions, and space agencies, with named engagements including Azenta Life Sciences and Imperial College London. Operations are anchored at the Medical Technologies Innovation Facility (MTIF) in Nottingham, with a secondary engineering presence at Space Park Leicester and a registered office in Birmingham.

Short descriptiontext

Frontier Space Technologies builds SpaceLab, a modular autonomous lab-in-a-box that enables pharmaceutical R&D and biomanufacturing in microgravity for pharmaceutical companies, biotech firms, and research institutions via tiered orbital mission services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNottingham, United Kingdom
HQ citystring
Nottingham
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microgravity research services, space biomanufacturing platforms, orbital pharmaceutical R&D, in-orbit laboratory systems, space biotech payloads
Industry3 codes
PRIMARYIMABACAB
Spacecraft & Satellites (Civil/Commercial)
SECONDARYIMABACAD
Space Payloads & Instruments (Sensors, Comms, EO/IR)
SECONDARYIMABACAM
Space Logistics & In-Orbit Servicing (Refueling, Tug, Debris Removal)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Guided Missiles & Space Vehicles & Parts3760
Product category
Space Biotechnology Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Orbital Research Services
TypeProfessional Services
Description

The company offers access to microgravity research environments for pharmaceutical and life sciences companies. Services range from passive sample testing at room temperature to fully customisable active experiments with in-situ data collection, microscopy, and bespoke thermal and atmospheric control.

frontier-space.co.uk
2SpaceLab Platform Licensing/Access
TypeOne Time License
Description

Customers access the SpaceLab platform for their own R&D experiments. The modular design allows tailored mission configurations with different sample discs and sensor options per mission.

frontier-space.co.uk
3Custom Mission Development
TypeProfessional Services
Description

Bespoke mission design and execution services including sample preparation, payload integration, environmental control customization, and data analysis support.

frontier-space.co.uk
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales
Pricing details2 tiers
1Entry-level passive testing starting from £1,200
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Budget-friendly option for trialing the service. Single sample kept safe at room temperature and atmospheric pressure. Return option available (launch dependent). Integration process captured for outreach and marketing purposes.

frontier-space.co.uk
2Bespoke high-end custom missions
ModelHybridBilling cadenceMulti-year contract
Notes

Fully customisable platform accommodating wide range of samples, multiple fluidic options, in-situ data collection including top-tier microscopy and imaging sensors, fully bespoke thermal and atmosphere control, return option, and high-security options.

frontier-space.co.uk
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Frontier Space Technologies designs, manufactures, and operates the SpaceLab platform — a CubeSat-specification modular autonomous "lab-in-a-box" used for in-orbit pharmaceutical research and biomanufacturing. The company sells orbital research services and custom mission development to pharmaceutical, biotechnology, academic, and government customers, with offerings ranging from entry-level passive sample testing to fully bespoke missions featuring active environmental control, microfluidics, and in-situ data collection. Strategic partnerships with multiple launch providers enable flexible mission scheduling and sample return capabilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Protein crystals grow larger and more uniformly in microgravity, enabling improved drug efficacy (e.g., Keytruda transition from IV to subcutaneous formulation)
+2 more records
Product overview1 text field

Frontier Space Technologies is a UK-based space biotech company offering a platform-plus-services architecture for in-space R&D and biomanufacturing. The core product is SpaceLab, a scalable modular 'lab-in-a-box' platform that enables pharmaceutical research and biomanufacturing in microgravity. SpaceLab comes in two generations: SpaceLab Mark 1 (initial demonstrator) and SpaceLab Mk 2 (improved version). Supporting products include the XSB platform and the proprietary Multi Chamber Sample Disc. The company offers tiered launch services ranging from budget-friendly 'Get me to Space' options (£1,200+) to fully customized 'Bells and Whistles' packages. Recent initiatives include space food biomanufacturing with ESA partnership. The company leverages partnerships with g-SPACE for AI/ML analytics integration and collaborates with The Exploration Company for spacecraft integration.

Product and service3 records
1SpaceLab
CategorySpace Biotechnology Platform
Description

Scalable, modular, autonomous 'lab-in-a-box' platform built to CubeSat specifications for in-orbit pharmaceutical research and biomanufacturing. Features advanced environmental control, fluorescence microscopy and spectrometry sensors, microfluidics systems, and the proprietary Multi Chamber Sample Disc enabling 4x sample density in a shoebox-sized form factor. Designed to interface with multiple launchers and recoverable vehicles. Validated through SpaceLab Mark 1 (April 2025) and SpaceLab Mk 2 (January 2026) orbital missions.

2XSB Platform
CategorySpace Biotechnology Platform
Description

XSB (cross-support interface for biological samples) platform technology providing scalable, flexible infrastructure for pharmaceutical R&D and biomanufacturing in orbit alongside SpaceLab. Designed to support biological sample handling and interface compatibility with multiple spacecraft platforms.

3Orbital Research Services
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2026-05-27
Description

Strategic partnership combining Frontier Space's in-orbit platforms with g-SPACE's physics-informed AI/ML analytics platform for microgravity data. The integrated solution provides end-to-end access to space-based biomanufacturing from experimental design through post-return analysis, with real-time tracking and optimisation of experiment performance.

2European Space for Health Alliance (ESHA)
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2026-04-08
Description

ESHA collaboration includes Frontier Space, The Exploration Company, ATMOS Space Cargo, and Future Centric. Alliance addresses Europe's need for continued microgravity research access post-ISS, focusing on standardised logistics, orbital transportation infrastructure, and translating space-enabled health research into medical progress on Earth.

frontier-space.co.uk
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-19
Description

Project BRIDGE is international collaboration between Frontier Space (UK), The Exploration Company (Germany), and US-based biopharmaceutical company, funded through UKSA IBF. Develops modular Cargo Handling System for secure transport and handling of biological materials in orbit and their safe return to Earth.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-01-29
Description

Relocated UK laboratory and integration activities to MTIF at Nottingham Trent University. MTIF provides ISO-classified cleanrooms, GLP- and GMP-certified laboratory infrastructure, and access to East Midlands Freeport, supporting the full space biotechnology lifecycle from sample preparation through payload integration.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-20
Description

Strategic partnership for the EGGS-2 microgravity mission to validate SpaceLab Mk 2 platform and test Azenta's FluidX sample management tubes under spaceflight conditions. The collaboration aims to demonstrate sample integrity technologies in demanding space environments and advance commercial space-based pharmaceutical research and biomanufacturing.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-20
Description

Provided KID capsule platform for EGGS-2 mission supporting payload integration and mission operations. Partnership enables rapid development cycles by allowing Frontier to fly SpaceLab Mk 2 just seven months after its first mission.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-22
Description

Partnership for EGGS-1 mission aboard SpaceX Bandwagon-3, flying SpaceLab Mark 1 inside ATMOS's Phoenix-1 capsule. Mission validated autonomous laboratory systems, microfluidics testing, and biological sample handling in microgravity. ATMOS provides commercial returnable spacecraft for Earth-to-space-to-Earth logistics.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-04-22
Description

Joint experiment with Professor Rodrigo Ledesma-Amaro testing space-readiness of freeze-dried biological samples in partnership with the Bezos Centre for Sustainable Protein and UKRI Microbial Food Hub. Experiment focuses on microorganism viability for potential food, pharmaceutical, and bioplastic production in space.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-18
Description

MOU signed to collaborate on microgravity research and transportation in Low Earth Orbit. Partnership includes developing interfaces between Frontier payloads and TEC's Nyx spacecraft, establishing joint mission frameworks, and engaging potential clients for LEO-based experiments. Part of UKSA IBF Project BRIDGE to develop modular Cargo Handling System for biological materials in orbit.

Strategic tierSupportingTypeGTM or Marketing PartnerAnnounced on2025-01-16
Description

Eight-week accelerator program between Mandala Space Ventures and UK Space Agency helping UK companies expand into US market. Included visits to Aerospace Corporation HQ, NASA's JPL, Vast, and Rocket Lab, concluding with Demo Day pitching to investors.

Strategic tierSupportingTypeGTM or Marketing PartnerAnnounced on2024-08-21
Description

Selected for 13th cohort of the Seraphim Space Accelerator, receiving guidance on fundraising, investor relations, board management, and access to network of space investors. Participated in London Kick-off, LA week, and London Final week events with pitching opportunities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-19
Description

Selected for UK Space Agency International Bilateral Fund (IBF) Phase 1 with The Exploration Company to explore viability of commercial in-orbit biopharma research on Nyx spacecraft. Subsequently awarded IBF funding to lead Project BRIDGE developing modular Cargo Handling System for biological materials.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers9 records
TypeDirect peer
Description

Germany-based microgravity research services provider offering access to in-orbit experiment platforms for life sciences and biotech customers. Direct competitor in the same product category and customer base as Frontier Space.

TypeDirect peer
Description

US-based space infrastructure company providing CubeSat-class autonomous platforms for in-orbit R&D and biomanufacturing. Closely comparable in modular lab-in-a-box architecture, customer segment, and CubeSat-spec design philosophy.

TypeBroad incumbent
Description

Public space infrastructure company with a deep biotech payload and in-orbit services portfolio (including the former Rhodium Scientific capability). Larger incumbent serving overlapping pharma/biotech R&D customers from a broader platform.

TypeBroad incumbent
Description

US in-space manufacturing company building return-capable orbital factories for high-value materials and pharmaceutical production. Broader scope than Frontier Space, but overlapping ambition in microgravity-based biomanufacturing.

TypeDirect peer
Description

University of Colorado-based research center with decades of experience flying biological and biotech payloads to ISS and commercial platforms. Directly comparable in serving pharma and life sciences R&D customers through orbital experimentation infrastructure.

TypeEmerging player
Description

Early-stage biotech manufacturing protein-based artificial retinas on the ISS. Overlaps with Frontier Space's microgravity biomanufacturing thesis and pharma/biotech end-market, though focused on a single therapeutic product application.

TypeOthers
Description

Commercial returnable capsule provider (Phoenix-1) and a Frontier Space launch partner on EGGS-1. Not a direct competitor but a critical enabling counterpart whose own execution directly affects Frontier's mission cadence.

TypeOthers
Description

European modular Nyx spacecraft developer and Frontier Space's strategic partner under UKSA Project BRIDGE. Adjacent ecosystem partner supplying orbital transportation that Frontier's SpaceLab platform integrates with.

TypeOthers
Description

UK-based return-capable capsule provider (KID) used by Frontier Space for the EGGS-2 mission. A launch ecosystem partner rather than direct competitor, but functionally critical to Frontier's mission economics and cadence.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frontier Space Technologies

Space Biotechnology Servicesfrontier-space.co.uk

Frontier Space Technologies builds SpaceLab, a modular autonomous lab-in-a-box that enables pharmaceutical R&D and biomanufacturing in microgravity for pharmaceutical companies, biotech firms, and research institutions via tiered orbital mission services.

What Frontier Space Technologies does

Frontier Space Technologies Ltd is a UK private space-biotech company founded in 2021 as a spin-out from Cranfield University by four graduates of the BAMMsat programme. The company develops SpaceLab, a CubeSat-specification, modular, autonomous "lab-in-a-box" platform that enables pharmaceutical R&D and biomanufacturing in microgravity. SpaceLab integrates a proprietary Multi Chamber Sample Disc delivering 4x sample density in a shoebox form factor, fluorescence microscopy and spectrometry sensors, advanced environmental control, and microfluidics for in-orbit cell culture and protein crystallisation. Two generations have been validated: SpaceLab Mark 1 (1.2U demonstrator) on the EGGS-1 mission in April 2025, and SpaceLab Mk 2 on the EGGS-2 mission in January 2026, the latter carrying 42 Azenta FluidX sample tubes and achieved in a roughly four-month design-to-launch cycle.

The business operates a platform-plus-services model, earning revenue from tiered orbital research services ranging from £1,200 entry-level passive sample testing through fully customised multi-year missions with bespoke thermal, atmospheric, and fluidic controls and onboard imaging. Distribution combines direct enterprise sales into pharma and biotech, channel partnerships with multiple launch providers and spacecraft OEMs (ATMOS Space Cargo, The Exploration Company, Orbital Paradigm), and government-funded programmes including UKSA IBF and AIEP. Customers span pharmaceutical and biotechnology firms (primary), academic and government research institutions, and space agencies, with named engagements including Azenta Life Sciences and Imperial College London. Operations are anchored at the Medical Technologies Innovation Facility (MTIF) in Nottingham, with a secondary engineering presence at Space Park Leicester and a registered office in Birmingham.

Frontier Space Technologies firmographics

Firmographics
Name
Frontier Space Technologies
Legal name
Frontier Space Technologies Ltd
Website
https://frontier-space.co.uk
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Frontier Space Technologies builds SpaceLab, a modular autonomous lab-in-a-box that enables pharmaceutical R&D and biomanufacturing in microgravity for pharmaceutical companies, biotech firms, and research institutions via tiered orbital mission services.
Ownership category
akta.pro rank

Frontier Space Technologies industry classification

Industry
Product category
Space Biotechnology Services
NAICS
Scientific Research and Development Services (5417)
SIC
Guided Missiles & Space Vehicles & Parts (3760)
akta.pro industry
PRIMARYIMABACAB
Spacecraft & Satellites (Civil/Commercial)
SECONDARYIMABACAD
Space Payloads & Instruments (Sensors, Comms, EO/IR)
SECONDARYIMABACAM
Space Logistics & In-Orbit Servicing (Refueling, Tug, Debris Removal)

Keywords

  • Microgravity research services
  • Space biomanufacturing platforms
  • Orbital pharmaceutical R&D
  • In-orbit laboratory systems
  • Space biotech payloads

Where Frontier Space Technologies is headquartered

Location

Headquarters

HQ city
Nottingham
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Frontier Space Technologies business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Orbital Research Services: The company offers access to microgravity research environments for pharmaceutical and life sciences companies. Services range from passive sample testing at room temperature to fully customisable active experiments with in-situ data collection, microscopy, and bespoke thermal and atmospheric control.
  2. SpaceLab Platform Licensing/Access: Customers access the SpaceLab platform for their own R&D experiments. The modular design allows tailored mission configurations with different sample discs and sensor options per mission.
  3. Custom Mission Development: Bespoke mission design and execution services including sample preparation, payload integration, environmental control customization, and data analysis support.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goEntry-level passive testing starting from £1,200
HybridMulti-year contractBespoke high-end custom missions

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Frontier Space Technologies product offering

Product offering

Core offering

Frontier Space Technologies designs, manufactures, and operates the SpaceLab platform — a CubeSat-specification modular autonomous "lab-in-a-box" used for in-orbit pharmaceutical research and biomanufacturing. The company sells orbital research services and custom mission development to pharmaceutical, biotechnology, academic, and government customers, with offerings ranging from entry-level passive sample testing to fully bespoke missions featuring active environmental control, microfluidics, and in-situ data collection. Strategic partnerships with multiple launch providers enable flexible mission scheduling and sample return capabilities.

Product overview

Frontier Space Technologies is a UK-based space biotech company offering a platform-plus-services architecture for in-space R&D and biomanufacturing. The core product is SpaceLab, a scalable modular 'lab-in-a-box' platform that enables pharmaceutical research and biomanufacturing in microgravity. SpaceLab comes in two generations: SpaceLab Mark 1 (initial demonstrator) and SpaceLab Mk 2 (improved version). Supporting products include the XSB platform and the proprietary Multi Chamber Sample Disc. The company offers tiered launch services ranging from budget-friendly 'Get me to Space' options (£1,200+) to fully customized 'Bells and Whistles' packages. Recent initiatives include space food biomanufacturing with ESA partnership. The company leverages partnerships with g-SPACE for AI/ML analytics integration and collaborates with The Exploration Company for spacecraft integration.

Differentiator

Problem solved

Functional benefit

Products and services

  • SpaceLab Scalable, modular, autonomous 'lab-in-a-box' platform built to CubeSat specifications for in-orbit pharmaceutical research and biomanufacturing. Features advanced environmental control, fluorescence microscopy and spectrometry sensors, microfluidics systems, and the proprietary Multi Chamber Sample Disc enabling 4x sample density in a shoebox-sized form factor. Designed to interface with multiple launchers and recoverable vehicles. Validated through SpaceLab Mark 1 (April 2025) and SpaceLab Mk 2 (January 2026) orbital missions.
  • XSB Platform XSB (cross-support interface for biological samples) platform technology providing scalable, flexible infrastructure for pharmaceutical R&D and biomanufacturing in orbit alongside SpaceLab. Designed to support biological sample handling and interface compatibility with multiple spacecraft platforms.
  • Orbital Research Services

Quantifiable outcome

  • Protein crystals grow larger and more uniformly in microgravity, enabling improved drug efficacy (e.g., Keytruda transition from IV to subcutaneous formulation)
  • +2 more outcomes

Companies that use Frontier Space Technologies

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Frontier Space Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Frontier Space Technologies partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered strategic, core and supporting.

  • g-SPACEstrategicTechnology or Integration · 27 May 2026Strategic partnership combining Frontier Space's in-orbit platforms with g-SPACE's physics-informed AI/ML analytics platform for microgravity data. The integrated solution provides end-to-end access to space-based biomanufacturing from experimental design through post-return analysis, with real-time tracking and optimisation of experiment performance.
  • European Space for Health Alliance (ESHA)strategicStrategic or Co-development Partner · 8 April 2026ESHA collaboration includes Frontier Space, The Exploration Company, ATMOS Space Cargo, and Future Centric. Alliance addresses Europe's need for continued microgravity research access post-ISS, focusing on standardised logistics, orbital transportation infrastructure, and translating space-enabled health research into medical progress on Earth.
  • Project BRIDGE PartnerscoreStrategic or Co-development Partner · 19 March 2026Project BRIDGE is international collaboration between Frontier Space (UK), The Exploration Company (Germany), and US-based biopharmaceutical company, funded through UKSA IBF. Develops modular Cargo Handling System for secure transport and handling of biological materials in orbit and their safe return to Earth.
  • Medical Technologies Innovation Facility (MTIF)coreImplementation/ SI/ Consulting Partner · 29 January 2026Relocated UK laboratory and integration activities to MTIF at Nottingham Trent University. MTIF provides ISO-classified cleanrooms, GLP- and GMP-certified laboratory infrastructure, and access to East Midlands Freeport, supporting the full space biotechnology lifecycle from sample preparation through payload integration.
  • Azenta Life SciencescoreStrategic or Co-development Partner · 20 January 2026Strategic partnership for the EGGS-2 microgravity mission to validate SpaceLab Mk 2 platform and test Azenta's FluidX sample management tubes under spaceflight conditions. The collaboration aims to demonstrate sample integrity technologies in demanding space environments and advance commercial space-based pharmaceutical research and biomanufacturing.
  • Orbital ParadigmcoreStrategic or Co-development Partner · 20 January 2026Provided KID capsule platform for EGGS-2 mission supporting payload integration and mission operations. Partnership enables rapid development cycles by allowing Frontier to fly SpaceLab Mk 2 just seven months after its first mission.
  • ATMOS Space CargocoreStrategic or Co-development Partner · 22 April 2025Partnership for EGGS-1 mission aboard SpaceX Bandwagon-3, flying SpaceLab Mark 1 inside ATMOS's Phoenix-1 capsule. Mission validated autonomous laboratory systems, microfluidics testing, and biological sample handling in microgravity. ATMOS provides commercial returnable spacecraft for Earth-to-space-to-Earth logistics.
  • Imperial College LondonstrategicStrategic or Co-development Partner · 22 April 2025Joint experiment with Professor Rodrigo Ledesma-Amaro testing space-readiness of freeze-dried biological samples in partnership with the Bezos Centre for Sustainable Protein and UKRI Microbial Food Hub. Experiment focuses on microorganism viability for potential food, pharmaceutical, and bioplastic production in space.
  • The Exploration CompanycoreStrategic or Co-development Partner · 18 March 2025MOU signed to collaborate on microgravity research and transportation in Low Earth Orbit. Partnership includes developing interfaces between Frontier payloads and TEC's Nyx spacecraft, establishing joint mission frameworks, and engaging potential clients for LEO-based experiments. Part of UKSA IBF Project BRIDGE to develop modular Cargo Handling System for biological materials in orbit.
  • Mandala Ventures / SoCal-UK Space AcceleratorsupportingGTM or Marketing Partner · 16 January 2025Eight-week accelerator program between Mandala Space Ventures and UK Space Agency helping UK companies expand into US market. Included visits to Aerospace Corporation HQ, NASA's JPL, Vast, and Rocket Lab, concluding with Demo Day pitching to investors.
  • Seraphim Space AcceleratorsupportingGTM or Marketing Partner · 21 August 2024Selected for 13th cohort of the Seraphim Space Accelerator, receiving guidance on fundraising, investor relations, board management, and access to network of space investors. Participated in London Kick-off, LA week, and London Final week events with pitching opportunities.
  • UK Space AgencycoreStrategic or Co-development Partner · 19 May 2024Selected for UK Space Agency International Bilateral Fund (IBF) Phase 1 with The Exploration Company to explore viability of commercial in-orbit biopharma research on Nyx spacecraft. Subsequently awarded IBF funding to lead Project BRIDGE developing modular Cargo Handling System for biological materials.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Frontier Space Technologies competitors and assessment

Company assessment

Direct peers

  • Yuri Microgravity Services: Germany-based microgravity research services provider offering access to in-orbit experiment platforms for life sciences and biotech customers. Direct competitor in the same product category and customer base as Frontier Space.
  • Space Tango: US-based space infrastructure company providing CubeSat-class autonomous platforms for in-orbit R&D and biomanufacturing. Closely comparable in modular lab-in-a-box architecture, customer segment, and CubeSat-spec design philosophy.
  • BioServe Space Technologies: University of Colorado-based research center with decades of experience flying biological and biotech payloads to ISS and commercial platforms. Directly comparable in serving pharma and life sciences R&D customers through orbital experimentation infrastructure.

Broad incumbents

  • Redwire Corporation: Public space infrastructure company with a deep biotech payload and in-orbit services portfolio (including the former Rhodium Scientific capability). Larger incumbent serving overlapping pharma/biotech R&D customers from a broader platform.
  • Varda Space Industries: US in-space manufacturing company building return-capable orbital factories for high-value materials and pharmaceutical production. Broader scope than Frontier Space, but overlapping ambition in microgravity-based biomanufacturing.

Emerging players

  • LambdaVision: Early-stage biotech manufacturing protein-based artificial retinas on the ISS. Overlaps with Frontier Space's microgravity biomanufacturing thesis and pharma/biotech end-market, though focused on a single therapeutic product application.

Others

  • ATMOS Space Cargo: Commercial returnable capsule provider (Phoenix-1) and a Frontier Space launch partner on EGGS-1. Not a direct competitor but a critical enabling counterpart whose own execution directly affects Frontier's mission cadence.
  • The Exploration Company: European modular Nyx spacecraft developer and Frontier Space's strategic partner under UKSA Project BRIDGE. Adjacent ecosystem partner supplying orbital transportation that Frontier's SpaceLab platform integrates with.
  • Orbital Paradigm: UK-based return-capable capsule provider (KID) used by Frontier Space for the EGGS-2 mission. A launch ecosystem partner rather than direct competitor, but functionally critical to Frontier's mission economics and cadence.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Frontier Space Technologies social profiles

Digital presence

Frontier Space Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Frontier Space Technologies leadership team

Management profile

Number of profiles

Profiles5 records

Frontier Space Technologies funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Frontier Space Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Frontier Space Technologies

What does Frontier Space Technologies do?

Frontier Space Technologies designs, manufactures, and operates the SpaceLab platform — a CubeSat-specification modular autonomous "lab-in-a-box" used for in-orbit pharmaceutical research and biomanufacturing. The company sells orbital research services and custom mission development to pharmaceutical, biotechnology, academic, and government customers, with offerings ranging from entry-level passive sample testing to fully bespoke missions featuring active environmental control, microfluidics, and in-situ data collection. Strategic partnerships with multiple launch providers enable flexible mission scheduling and sample return capabilities.

Is Frontier Space Technologies a public or private company?

Frontier Space Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Frontier Space Technologies founded?

Frontier Space Technologies was founded in 2021. It employs 1 to 10 people.

Where is Frontier Space Technologies based?

Frontier Space Technologies is headquartered in Nottingham, United Kingdom, in the Europe region.

How does Frontier Space Technologies make money?

Three revenue lines are on record. Orbital Research Services are the primary driver. The others are spaceLab Platform Licensing/Access and custom Mission Development.

Who are Frontier Space Technologies's main competitors?

Direct peers on record are Yuri Microgravity Services, Space Tango and BioServe Space Technologies. Broad incumbents are Redwire Corporation and Varda Space Industries. LambdaVision is listed as an emerging player. Others are ATMOS Space Cargo, The Exploration Company and Orbital Paradigm.

Does Frontier Space Technologies have an API?

No public API is recorded for Frontier Space Technologies.

What industry is Frontier Space Technologies in?

Frontier Space Technologies's product category is Space Biotechnology Services. Its primary akta.pro industry code is IMABACAB, Spacecraft & Satellites (Civil/Commercial), with a secondary code of IMABACAD, Space Payloads & Instruments (Sensors, Comms, EO/IR). Its NAICS code is 5417 and its SIC code is 3760.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
News-MedicalAtelerix and Frontier Space partner to enable biological sample preservation for space missionsAtelerix and Frontier Space signed a two-year MoU to validate Atelerix's alginate hydrogel encapsulation technology for preserving biological samples during microgravity missions. The partnership aims to reduce reliance on cryogenic storage, potentially saving up to $30,000 in launch costs. Launch opportunities are targeted throughout 2027.Business Wire BlogAtelerix and Frontier Space Partner to Enable Biological Sample Preservation for Space MissionsAtelerix and Frontier Space signed a two-year MoU to validate Atelerix's alginate hydrogel encapsulation technology for preserving biological samples during microgravity missions. The partnership aims to reduce payload mass and launch costs, with targets to save up to $30,000 per launch by removing cryogenic storage. Launch opportunities are targeted for 2027.FinancialContent Business PageAtelerix and Frontier Space Partner to Enable Biological Sample Preservation for Space MissionsAtelerix and Frontier Space signed a two-year MoU to validate Atelerix's alginate hydrogel encapsulation technology for preserving biological samples during microgravity missions. The partnership aims to reduce payload mass and launch costs, with Frontier Space estimating savings of up to $30,000 per launch. Launch opportunities are targeted for 2027.WorldbiomarketinsightsSpace foodtech takes offNASA's Artemis II mission demonstrated the limits of manned space travel at 252,756 miles from Earth, highlighting the need for sustainable food production beyond current pre-packaged rations. The European Space Agency is partnering with Finnish startup Solar Foods and UK-based Frontier Space to trial space food biomanufacturing technologies aboard the International Space Station, including Solar Foods' Solein protein powder made from astronaut urine and Frontier's yeast-based precision fermentation bioreactors. Governments including the UK and China are investing in space biomanufacturing research, with broader implications for scaling sustainable food production on Earth.News-MedicalEnhancing structural biology with microgravity-grown protein crystalsFrontier Space Technologies and ELRIG (UK) Ltd. presented findings at the ELRIG Drug Discovery 2025 conference highlighting how microgravity environments enhance structural biology by producing higher-quality protein crystals and more accurate 3D cell cultures. The article details successful collaborations, including Merck's improved crystallization of Keytruda on the ISS and Amgen's accelerated bone loss research, demonstrating reduced clinical trial attrition and faster drug development. These advancements are being supported by new orbital platforms like Frontier SpaceLab designed to automate and scale space-enabled biotechnology for the pharmaceutical industry.TechCrunchFrontier Space Technologies is developing an on-orbit autonomous lab to make space science easyFrontier Space Technologies is developing SpaceLab, a small autonomous on-orbit lab that runs multiple microgravity experiments without crew time. The 3U CubeSat uses a multi-chamber sample disc to isolate and manipulate samples, and the company has raised $270,000 in grants and secured a commercial contract. It plans its first on-orbit demonstrations in Q4 2024.